ch.oddb.org 
German | English | French
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Home<List for "R03DX" (21)–Sort according to Concentration, Size and Price
     ProductPackage SizeEFPCPSBDCCompositionRegistr. HolderCategory  
Omalizumab (R03DX05) 12 products WHO-DDD DrugBank.ca 
L IPCI Xolair 75 mg/0.5 ml 166.63194.9010 %Injection solution in prefilled syringe: Omalizumabum 75mg / 0.5mlNovartis Pharma
Schweiz AG		B / SL / SOG
L IPCI Xolair 75 mg/0.5 ml 166.63194.9010 %Injection solution in prefilled syringe: Omalizumabum 75mg / 0.5mlNovartis Pharma
Schweiz AG		B / SL / SOG
L IPCI Xolair 150 mg/1.0 ml 333.25373.3510 %Injection solution in prefilled syringe: Omalizumabum 150mg / 1mlNovartis Pharma
Schweiz AG		B / SL / SOG
L IPCI Xolair 150 mg/1.0 ml 333.25373.3510 %Injection solution in prefilled syringe: Omalizumabum 150mg / 1mlNovartis Pharma
Schweiz AG		B / SL / SOG
LSIPIPCI Xolair 150 mgampoule(s)333.25373.3510 %Lyophilisate and solvent: Omalizumabum 150 mgNovartis Pharma
Schweiz AG		B / SL / SOG
L IPCI Xolair 150 mg/1.0 ml 333.25373.3510 %Injektionslösung in einem Fertigpen: Omalizumabum 150 mg/mlNovartis Pharma
Schweiz AG		B / SL / SOG
L IPCI Omlyclo 75 mg/0.5 ml 122.15149.2510 %solution injectable en seringue préremplie: Omalizumabum 75mg / 0.5mliQone Healthcare
Switzerland SA		B / SL / SGG
L IPCI Omlyclo 150 mg/1 ml 244.29282.1010 %solution injectable en seringue préremplie: Omalizumabum 150 mg/mliQone Healthcare
Switzerland SA		B / SL / SGG
L IPCI Xolair 300 mg/2 ml 666.50741.2510 %Injection solution in prefilled syringe: Omalizumabum 300mg / 2mlNovartis Pharma
Schweiz AG		B / SLG
L IPCI Xolair 300 mg/2.0 ml 666.50741.2510 %Injektionslösung in einem Fertigpen: Omalizumabum 300mg / 2mlNovartis Pharma
Schweiz AG		B / SLG
 SIPIPCI Xolair 75 mgampoule(s)k.A.Lyophilisate and solvent: Omalizumabum 75 mgNovartis Pharma
Schweiz AG		BG
  IPCI Xolair 75 mg/0.5 ml k.A.Injektionslösung in einem Fertigpen: Omalizumabum 75mg / 0.5mlNovartis Pharma
Schweiz AG		BG
Roflumilast (R03DX07) 1 products WHO-DDD DrugBank.ca 
  IPCI Daxas 500 ug30 Tablet(s)54.0675.2010 %Coated tablets: Roflumilastum 500 µgAstraZeneca AGB / SLG
Reslizumab (R03DX08) 2 products WHO-DDD  
L IP  Cinqaero 100 mg/10 mL 510.32571.4010 %Concentrate for infusion: Reslizumabum 100mg / 10mlTeva Pharma AGB / SLG
L IP  Cinqaero 25 mg/2,5 mL 127.59155.2010 %Concentrate for infusion: Reslizumabum 25mg / 2.5mlTeva Pharma AGB / SLG
Mepolizumab (R03DX09) 2 products WHO-DDD  
L IPCI Nucala 100 mg/mL 917.411014.1510 %Injektionslösung im Fertigpen: Mepolizumabum 100mg / 1mlGlaxoSmithKline AGB / SLG
L IPCI Nucala 100 mg/mL 917.411014.1510 %Injektionslösung in der Fertigspritze: Mepolizumabum 100mg / 1mlGlaxoSmithKline AGB / SLG
Benralizumab (R03DX10) 2 products WHO-DDD  
L IPCI Fasenra 30 mg /1 ml 1929.052114.3510 %Injection solution in prefilled syringe: Benralizumabum 30 mg/mlAstraZeneca AGB / SLG
L IPCI Fasenra Pen 30 mg /1 ml 1929.052114.3510 %lnjektionslösung: Benralizumabum 30 mg/mlAstraZeneca AGB / SLG
Tezepelumab (R03DX11) 2 products WHO-DDD  
L IPCI Tezspire 995.241098.8010 %Injection solution in prefilled syringe: Tezepelumabum 210 mgAstraZeneca AGB / SLG
L IPCI Tezspire 110 mg/ml 995.241098.8010 %Injektionslösung in einem Fertigpen: Tezepelumabum 210 mgAstraZeneca AGB / SLG
 show caption
 
ATC-Browser | Drugs A-Z | Recent Registrations
2026 ©ywesee GmbH
Settings | Help | Login | Contact | Home